Weigao Group Flags Subsidiary Disclosure on Shanghai Stock Exchange

Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has shared an update.

Shandong Weigao Group Medical Polymer Company Limited announced that, in accordance with Hong Kong listing disclosure rules, it is drawing investors’ attention to an announcement by its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, published on the Shanghai Stock Exchange’s website. The Hong Kong-listed parent emphasized that the subsidiary’s disclosure has been released on the Chinese section of the exchange site, reinforcing cross-market transparency requirements for investors in both Hong Kong and mainland China.

The board, chaired by Long Jing, formally approved the notice, listing the current composition of executive, non-executive, and independent non-executive directors. While the content of the subsidiary’s Shanghai announcement was not detailed, the move underscores the group’s obligation to synchronize material disclosures across its dual-market presence, ensuring regulatory compliance and consistent information flow to shareholders.

The most recent analyst rating on (HK:1066) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.

More about Shandong Weigao Group Medical Polymer Co

Shandong Weigao Group Medical Polymer Company Limited is a PRC-incorporated medical device manufacturer focused on medical polymer products and orthopaedic devices. The company is listed in Hong Kong under stock code 1066 and operates through subsidiaries including Shandong Weigao Orthopaedic Device Company Limited, which is listed on the Shanghai Stock Exchange.

Average Trading Volume: 13,468,586

Technical Sentiment Signal: Sell

Current Market Cap: HK$23.15B

See more data about 1066 stock on TipRanks’ Stock Analysis page.